{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:09:31Z","timestamp":1789027771349,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210037"],"award-info":[{"award-number":["RP210037"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10552-026-02238-w","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T15:30:20Z","timestamp":1788103820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal changes in sex and race\/ethnicity incidence rate ratios for hepatocellular carcinoma in the United States, 1992\u20132022"],"prefix":"10.1007","volume":"37","author":[{"given":"Samantha K.","family":"Sarlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyeun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Thrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2238_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun HC, Xu Y et al (2025) The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet 406:731\u2013778. https:\/\/doi.org\/10.1016\/S0140-6736(25)01042-6","journal-title":"Lancet"},{"key":"2238_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"2238_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"2238_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091431","author":"IO Sokale","year":"2001","unstructured":"Sokale IO, Rosales O, Thrift AP et al (2001) Differences in hepatocellular carcinoma incidence trends across US census divisions, 2001 to 2021. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17091431","journal-title":"Cancers (Basel)"},{"key":"2238_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1158\/1055-9965.EPI-19-1052","volume":"29","author":"X Zhang","year":"2020","unstructured":"Zhang X, El-Serag HB, Thrift AP (2020) Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 29:88\u201394. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-1052","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2238_CR6","first-page":"172","volume":"12","author":"Y Abboud","year":"2024","unstructured":"Abboud Y, Ismail M, Khan H et al (2024) Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades. J Clin Transl Hepatol 12:172\u2013181","journal-title":"J Clin Transl Hepatol"},{"key":"2238_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.17226\/10028","volume":"10","author":"Exploring the biological contributions to human health","year":"2001","unstructured":"Exploring the biological contributions to human health (2001) Does sex matter? J Womens Health Gend Based Med 10:433\u2013439. https:\/\/doi.org\/10.17226\/10028","journal-title":"J Womens Health Gend Based Med"},{"key":"2238_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","volume":"152","author":"DL White","year":"2017","unstructured":"White DL, Thrift AP, Kanwal F et al (2017) Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology 152:812-820.e5. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.020","journal-title":"Gastroenterology"},{"key":"2238_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.07.034","author":"AP Thrift","year":"2022","unstructured":"Thrift AP, Liu KS, Raza SA et al (2022) Recent decline in the incidence of hepatocellular carcinoma in the United States. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2022.07.034","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2238_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309465","volume":"19","author":"S Adra","year":"2024","unstructured":"Adra S, Alabrach Y, Hashem A et al (2024) Trends of primary liver cancer incidence and mortality in the United States: a population-based study over the last four decades. PLoS ONE 19:e0309465. https:\/\/doi.org\/10.1371\/journal.pone.0309465","journal-title":"PLoS ONE"},{"key":"2238_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.cgh.2024.11.012","volume":"23","author":"G Cholankeril","year":"2025","unstructured":"Cholankeril G, Thrift AP, Khaderi S et al (2025) Temporal changes in risk factors of hepatocellular carcinoma in a prospective cirrhosis cohort. Clin Gastroenterol Hepatol 23:1268\u20131270. https:\/\/doi.org\/10.1016\/j.cgh.2024.11.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2238_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/hep.32434","volume":"77","author":"F Kanwal","year":"2023","unstructured":"Kanwal F, Khaderi S, Singal AG et al (2023) Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology 77:997\u20131005. https:\/\/doi.org\/10.1002\/hep.32434","journal-title":"Hepatology"},{"key":"2238_CR13","unstructured":"SEER (2025) Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2023) (www.seer.cancer.gov\/popdata), National Cancer Institute, DCCPS, Surveillance Research Program, released February 2025"},{"key":"2238_CR14","unstructured":"Joinpoint Regression Program NCI. Joinpoint Regression Software, Version 5.4.0 - April 2025, 2025."},{"key":"2238_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ et al (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335\u2013351","journal-title":"Stat Med"},{"key":"2238_CR16","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","volume":"34","author":"JL Petrick","year":"2016","unstructured":"Petrick JL, Kelly SP, Altekruse SF et al (2016) Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol 34:1787\u20131794. https:\/\/doi.org\/10.1200\/JCO.2015.64.7412","journal-title":"J Clin Oncol"},{"issue":"3","key":"2238_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.32394","volume":"76","author":"CS Alvarez","year":"2022","unstructured":"Alvarez CS, Petrick JL, Parisi D, McMahon BJ, Graubard BI, McGlynn KA (2022) Racial\/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018. Hepatology 76(3):589\u2013598. https:\/\/doi.org\/10.1002\/hep.32394","journal-title":"Hepatology"},{"issue":"4","key":"2238_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A (2019) Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 70(4):1457\u20131469. https:\/\/doi.org\/10.1002\/hep.30626","journal-title":"Hepatology"},{"key":"2238_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/dmrr.1291","volume":"28","author":"P Wang","year":"2012","unstructured":"Wang P, Kang D, Cao W et al (2012) Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 28:109\u2013122. https:\/\/doi.org\/10.1002\/dmrr.1291","journal-title":"Diabetes Metab Res Rev"},{"key":"2238_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R et al (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67:123\u2013133. https:\/\/doi.org\/10.1002\/hep.29466","journal-title":"Hepatology"},{"key":"2238_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D et al (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"6","key":"2238_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/hep.32265","volume":"75","author":"W He","year":"2022","unstructured":"He W, Guo GN, Li C (2022) The impact of hepatitis B vaccination in the United States, 1999\u20132018. Hepatology 75(6):1566\u20131578. https:\/\/doi.org\/10.1002\/hep.32265","journal-title":"Hepatology"},{"issue":"2","key":"2238_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70848","volume":"98","author":"Y Lin","year":"2017","unstructured":"Lin Y, Hou Y, Chen Z, Zhang Y, Agins B, She Y et al (2017) Hepatitis B vaccination coverage and vaccine\u2010associated immunity among US\u2010born children and adolescents:NHANES 2017\u20132020. J Med Virol 98(2):e70848. https:\/\/doi.org\/10.1002\/jmv.70848","journal-title":"J Med Virol"},{"issue":"4","key":"2238_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1053\/j.gastro.2018.07.008","volume":"155","author":"D Kim","year":"2007","unstructured":"Kim D, Li AA, Gadiparthi C, Khan MA, Cholankeril G, Glenn JS et al (2007) Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016. Gastroenterology 155(4):1154-1163.e3. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.008","journal-title":"Gastroenterology"},{"issue":"10381","key":"2238_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV (2023) Lok ASF. Hepatitis B Lancet 401(10381):1039\u20131052. https:\/\/doi.org\/10.1016\/S0140-6736(22)01468-4","journal-title":"Hepatitis B Lancet"},{"issue":"21","key":"2238_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.6070","volume":"335","author":"WJ Jeng","year":"2026","unstructured":"Jeng WJ, Yip TCF, Lok AS (2026) Hepatitis B: a review. JAMA 335(21):1879. https:\/\/doi.org\/10.1001\/jama.2026.6070","journal-title":"JAMA"},{"issue":"6","key":"2238_CR27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/1475-6773.13994","volume":"57","author":"KM Clements","year":"2013","unstructured":"Clements KM, Kunte PS, Clark MA, Gurewich D, Greenwood BC, Sefton L et al (2013) Uptake of hepatitis C virus treatment in a multi\u2010state Medicaid population, 2013\u20132017. Health Serv Res 57(6):1312\u20131320. https:\/\/doi.org\/10.1111\/1475-6773.13994","journal-title":"Health Serv Res"},{"issue":"7","key":"2238_CR28","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/acer.15335","volume":"48","author":"WC Kerr","year":"2024","unstructured":"Kerr WC, Lui CK, Ye Y, Li L, Greenfield T, Karriker-Jaffe KJ et al (2024) Long-term trends in beverage-specific drinking in the National Alcohol Surveys: differences by sex, age, and race and ethnicity. Alcohol Clin Exp Res 48(7):1322\u20131335. https:\/\/doi.org\/10.1111\/acer.15335","journal-title":"Alcohol Clin Exp Res"},{"issue":"46","key":"2238_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000045793","volume":"104","author":"U Idrees","year":"1999","unstructured":"Idrees U, Nasir S, Marsool MD, Saeed H, Fatima Z, Mujeeb A et al (1999) Exploring the landscape of viral hepatitis: a comprehensive retrospective analysis of mortality trends and disparities in the United States (1999-2020). Medicine (Baltimore) 104(46):e45793. https:\/\/doi.org\/10.1097\/MD.0000000000045793","journal-title":"Medicine (Baltimore)"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02238-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02238-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02238-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:49:12Z","timestamp":1789026552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02238-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2238"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02238-w","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used de-identified, publicly available SEER data and was exempt from institutional review board approval.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"153"}}